NuSkin Enterprises NUS Manufacturing — D&A
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by NuSkin Enterprises in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The official record: NuSkin Enterprises’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about NuSkin Enterprises's manufacturing — d&a.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is NuSkin Enterprises's manufacturing — D&A?
- NuSkin Enterprises (NUS) reported manufacturing — D&A of $3.25M in Q1 2026.
- How has NuSkin Enterprises's manufacturing — D&A changed year-over-year?
- NuSkin Enterprises's manufacturing — D&A decreased by 2.5% year-over-year, from $3.33M to $3.25M.
- What is the long-term trend for NuSkin Enterprises's manufacturing — D&A?
- Over 4 years (2021 to 2025), NuSkin Enterprises's manufacturing — D&A has grown at a 3.0% compound annual growth rate (CAGR), from $11.77M to $13.22M.
- What does manufacturing — D&A mean?
- The non-cash expense allocated to the manufacturing segment to account for the gradual wear and tear or expiration of long-lived assets. This metric reflects the capital intensity of the segment's operations and the ongoing need for asset replacement. It is a vital component for calculating the segment's cash flow and true economic profitability.